KBC Group NV Has $3.93 Million Stake in Doximity, Inc. (NASDAQ:DOCS)

KBC Group NV grew its position in Doximity, Inc. (NASDAQ:DOCS) by 2,130.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 73,523 shares of the company’s stock after buying an additional 70,227 shares during the quarter. KBC Group NV’s holdings in Doximity were worth $3,925,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in DOCS. FMR LLC raised its stake in Doximity by 30.5% during the third quarter. FMR LLC now owns 6,837,733 shares of the company’s stock worth $297,920,000 after acquiring an additional 1,598,602 shares in the last quarter. Lord Abbett & CO. LLC acquired a new position in Doximity during the 3rd quarter worth approximately $29,453,000. Los Angeles Capital Management LLC lifted its stake in Doximity by 6,242.6% in the 3rd quarter. Los Angeles Capital Management LLC now owns 650,874 shares of the company’s stock valued at $28,359,000 after purchasing an additional 640,612 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in Doximity in the third quarter valued at approximately $24,691,000. Finally, Geode Capital Management LLC grew its stake in shares of Doximity by 19.8% during the third quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock worth $124,503,000 after buying an additional 472,565 shares during the last quarter. Institutional investors own 87.19% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Truist Financial raised their price objective on Doximity from $35.00 to $49.00 and gave the company a “hold” rating in a report on Thursday, November 14th. Bank of America lifted their price target on Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a research note on Monday, January 6th. Wells Fargo & Company upped their price objective on Doximity from $41.00 to $43.00 and gave the company an “equal weight” rating in a research note on Monday, January 13th. Canaccord Genuity Group downgraded shares of Doximity from a “buy” rating to a “hold” rating and lifted their target price for the stock from $40.00 to $60.00 in a research report on Wednesday, November 13th. Finally, Barclays upped their price target on shares of Doximity from $52.00 to $75.00 and gave the company an “overweight” rating in a research report on Monday, November 11th. Thirteen research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $53.12.

Doximity Stock Up 0.4 %

NASDAQ:DOCS opened at $59.22 on Friday. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $61.75. The company has a fifty day moving average of $54.57 and a 200-day moving average of $44.48. The firm has a market capitalization of $11.06 billion, a P/E ratio of 68.06, a P/E/G ratio of 4.56 and a beta of 1.38.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.26 by ($0.02). The company had revenue of $136.83 million during the quarter, compared to the consensus estimate of $127.05 million. Doximity had a net margin of 33.69% and a return on equity of 19.79%. During the same period last year, the firm posted $0.18 earnings per share. On average, analysts anticipate that Doximity, Inc. will post 0.88 EPS for the current fiscal year.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.